Edwards Lifesciences (EW) Total Non-Current Liabilities (2016 - 2025)
Edwards Lifesciences (EW) has 17 years of Total Non-Current Liabilities data on record, last reported at $2.7 billion in Q3 2025.
- For Q3 2025, Total Non-Current Liabilities fell 10.95% year-over-year to $2.7 billion; the TTM value through Sep 2025 reached $2.7 billion, down 10.95%, while the annual FY2024 figure was $2.6 billion, 9.0% up from the prior year.
- Total Non-Current Liabilities reached $2.7 billion in Q3 2025 per EW's latest filing, up from $2.5 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $3.0 billion in Q3 2024 and bottomed at $2.2 billion in Q2 2022.
- Average Total Non-Current Liabilities over 5 years is $2.4 billion, with a median of $2.4 billion recorded in 2021.
- Peak YoY movement for Total Non-Current Liabilities: rose 26.37% in 2024, then dropped 10.95% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $2.4 billion in 2021, then grew by 2.51% to $2.5 billion in 2022, then decreased by 2.73% to $2.4 billion in 2023, then rose by 9.0% to $2.6 billion in 2024, then rose by 3.71% to $2.7 billion in 2025.
- Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $2.7 billion in Q3 2025, $2.5 billion in Q2 2025, and $2.5 billion in Q1 2025.